Back to Search Start Over

Latent constructs identified in older individuals who smoke cigarettes and are eligible for lung cancer screening: Factor analysis of baseline data from the PLUTO smoking cessation trial

Authors :
Abbie Begnaud
Steven S. Fu
Bruce Lindgren
Anne Melzer
Alexander J. Rothman
Kelsey Schertz
David M. Vock
Anne M. Joseph
Source :
Contemporary Clinical Trials Communications, Vol 29, Iss , Pp 100977- (2022)
Publication Year :
2022
Publisher :
Elsevier, 2022.

Abstract

Introduction: Lung cancer screening (LCS) combined with smoking cessation intervention is currently recommended for older individuals with a history of heavy smoking. Tailoring tobacco treatment for this patient population of older, people who smoke (PWS) may improve cessation rates while efficiently using limited smoking cessation resources. Although some older people who smoke will need more intensive treatment to achieve sustained abstinence, others may be successful with less intensive treatment. A framework to identify them a priori would be helpful to distribute smoking cessation resources accordingly. Methods: Baseline demographic, smoking, and health data are reported from a randomized clinical trial of longitudinal smoking cessation interventions delivered in the setting of LCS. Candidate variables were factor analyzed to identify latent factors, or constructs, to identify subgroups of older participants among the heterogenous population of older people who smoke. Results: We identified three factor-derived constructs: self-reported health status, heaviness of smoking, and nicotine dependence. Nicotine dependence was moderately correlated with both of the other two factors. Conclusions: This factor analysis of baseline participant characteristics identified a set of latent constructs – based on a few practical clinical variables -- that can be used to classify the heterogenous population of older people who smoke to identify. We propose this framework to identify subgroups of people who smoke who might successfully quit with less intense treatment at the time of lung cancer screening.

Subjects

Subjects :
Medicine (General)
R5-920

Details

Language :
English
ISSN :
24518654
Volume :
29
Issue :
100977-
Database :
Directory of Open Access Journals
Journal :
Contemporary Clinical Trials Communications
Publication Type :
Academic Journal
Accession number :
edsdoj.f85a18fa4b094a2cb20200a5adc766ea
Document Type :
article
Full Text :
https://doi.org/10.1016/j.conctc.2022.100977